73969-8
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Active
Term Description
The probability risk for trisomy 13 can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal sex chromosome aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.
Part Description
LP99499-3 Fetal trisomy 13 risk
Trisomy 13 risk refers to the fetus's risk of having trisomy 13. The risk can be estimated based on maternal age as well as prenatal genetic testing of fetal DNA. Trisomy 13, also called Patau syndrome, is caused by the presence of three copies of chromosome 13 in each cell rather than two. Patau syndrome is associated with severe cognitive delay, various forms of congenital heart disease, brain or spinal cord abnormalities, hypotonia, cleft lip and/or palate, and poorly developed eyes. Many liveborn infants with Patau syndrome die within the first weeks of life, and less than 10% survive longer than one year. The general population risk of Trisomy 13 is about 1 in 16,000 live births, but the risk increases with increasing maternal age. [MedlinePlus Condition: trisomy-13]
Source: Regenstrief LOINC
, GHR: Trisomy 13
Fully-Specified Name
- Component
- Fetal trisomy 13 risk
- Property
- Likelihood
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Long Common Name
- Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
- Short Name
- Fet Ts 13 risk Plas.cfDNA Qn
- Display Name
- Trisomy 13 risk Dosage of chromosome-specific cfDNA Qn (cfDNA)
- Consumer Name Alpha Get Info
- Fetal Trisomy 13 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.44
- Last Updated
- Version 2.73 (MIN)
- Change Reason
- The system of 'Ser/Plas.maternal^fetus' was changed to 'Plas.cfDNA' (cfDNA from plasma, which includes both maternal and fetal DNA) to more precisely identify what is being measured.; Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 9445
Member of these Panels
LOINC | Long Common Name |
---|---|
73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
el-GR | Greek (Greece) | Κίνδυνος εμβρυϊκής τρισωμίας 13: Synonyms: Κίνδυνος εμβρυϊκής τρισωμίας 13 Πιθανότητα |
es-ES | Spanish (Spain) | Riesgo de trisomía 13: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Riesgo de trisomía 13 fetal: |
fr-FR | French (France) | Risque de trisomie 13 foetale: |
it-IT | Italian (Italy) | Trisomia 13, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 13 Trisomia cromosoma genetica |
pt-BR | Portuguese (Brazil) | Trissomia 13 risco: |
zh-CN | Chinese (China) | 胎儿三体型 13 风险: Synonyms: 三体型 三体细胞 三染色体性 三染色体细胞 分子病理学; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=73969-8
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://